ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,127.79
1.26%
Dow Jones
38,675.68
1.18%
US Dollar vs MXN
16.9724
0.00%
Brent Oil
82.765
0.00%
Bitcoin
63,100.77
-1.24%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NYSE
  6. Clarivate PLC (CLVT)

  7. Clarivate PLC (CLVT) Noticias

CLVT Clarivate PLC

6.85
-0.09 (-1.30%)
03 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Clarivate PLC CLVT NYSE Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
-0.09 -1.30% 6.85 15:56:48
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
7.06 6.84 7.14 6.85 6.94
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
02/5/202402:00PRNUSClarivate Enhances Cortellis CMC Intelligence with..
01/5/202415:05PRNUSClarivate Declares Dividend on Mandatory Convertible..
30/4/202402:00PRNUSBioWorld by Clarivate Explores the Future of CAR T Therapy..
24/4/202402:00PRNUSClarivate joins United Nations SDG Publishers Compact
23/4/202406:00PRNUSClarivate Acquires Global QMS, Inc., Expanding Life Sciences..
17/4/202403:00PRNUSClarivate Launches LatAm Market Tracking Solution in..
15/4/202408:00PRNUSClarivate to Report First Quarter 2024 Results on May 8,..
01/4/202408:00PRNUSClarivate Leadership Presents at Recent Investor Conferences
21/3/202403:00PRNUSClarivate Acquires AI Start Up to Accelerate Strategy and..
20/3/202407:00PRNUSNew Webinar: Clarivate in the Age of AI - Driving Innovation..
13/3/202407:00PRNUSNew Webinar: Clarivate in the Age of AI - Empowering Our..
07/3/202407:00PRNUSClarivate to Present at the BofA Securities 2024 Information..
06/3/202407:00PRNUSNew Webinar: Clarivate in the Age of AI - Innovation Rooted..
05/3/202402:00PRNUSClarivate Reveals Top 100 Global Innovators 2024
04/3/202407:30PRNUSClarivate and Exor Sign Agreement Under Which Suzanne..
27/2/202405:00PRNUSClarivate Reports Fourth Quarter and Full Year 2023 Results
23/2/202402:00PRNUSClarivate Recognized in the WTR 1000 2024 for Trademark..
20/2/202402:00PRNUSClarivate Launches New Center for Intellectual Property and..
12/2/202402:00PRNUSClarivate Partners with the Financial Times to Power its..
01/2/202406:00PRNUSClarivate Completes Refinancing of Term Loan and Revolver..
29/1/202402:00PRNUSClarivate Launches Web of Science Grants Index to Help..
24/1/202406:00PRNUSClarivate to Report Fourth Quarter and Full Year 2023..
22/1/202406:00PRNUSClarivate Announces Commencement of Term Loan Refinancing..
08/1/202402:00PRNUSClarivate Identifies Thirteen Potential Blockbuster Drugs..
19/12/202301:00PRNUSClarivate Reveals Stronger Outlook for Pulsed-field Ablation..
05/12/202301:00PRNUSClarivate Expands Partnership with VeriSIM Life to..
15/11/202302:00PRNUSClarivate Reveals World's Influential Researchers in Highly..
08/11/202315:15PRNUSClarivate to Present at the RBC Capital Markets 2023..
07/11/202305:00PRNUSClarivate Reports Third Quarter 2023 Results
31/10/202302:00PRNUSClarivate Report Reveals China Challenging U.S. Research..
26/10/202302:00PRNUSClarivate Partners with EveryLibrary to Support and Nurture..
24/10/202302:00PRNUSBioWorld by Clarivate Examines Impact of Emerging Medicines..
18/10/202302:00PRNUSClarivate Renews Partnership with The Federal Library and..
16/10/202308:00PRNUSClarivate to Report Third Quarter 2023 Results on November..
12/10/202302:00PRNUSClarivate Report Finds Significant Adoption of AI in IP
11/10/202303:00PRNUSClarivate Healthcare Business Insights Announces 2022..
10/10/202302:00PRNUSClarivate Accurately Forecasts Four New 2023 Nobel Prize..
03/10/202302:00PRNUSYale University Selects Clarivate to Provide Their Next..
27/9/202302:00PRNUSSeven AI/ML for Life Sciences Companies Identified as..
26/9/202302:00PRNUSClarivate Establishes Academia & Government Innovation..
20/9/202302:00PRNUSClarivate Launches AI-Powered Tool to Simplify IP Budgets..
19/9/202302:00PRNUSClarivate Unveils Citation Laureates 2023 - Annual List of..
18/9/202306:00PRNUSClarivate Announces Termination of Tax Benefits Preservation..
30/8/202302:00PRNUSClarivate Annual G20 Scorecard Analyzes Global Research..
24/8/202307:30PRNUSClarivate to Present at the Goldman Sachs Communacopia +..
17/8/202302:00PRNUSNew Clarivate Trends Data Shows California, New York, Texas,..
16/8/202302:00PRNUSOhioLINK selects Ex Libris Alma and Primo as next library..
09/8/202302:00PRNUSClarivate Launches Enhanced Search Powered by Generative..
03/8/202307:00PRNUSClarivate to Present at Oppenheimer's 26th Annual..
03/8/202305:00PRNUSClarivate Reports Second Quarter 2023 Results

Su Consulta Reciente

NYSE
CLVT
Clarivate
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados